董辰方医学院基础医学肿瘤学个人简介:董辰方，教授、博士生导师；浙江省疾病蛋白质组学重点实验室副主任；浙江大学医学院肿瘤研究中心、病理与病理生理系肿瘤转移机制研究课题组组长。 在肿瘤转移领域，特别是代谢重编程/表观遗传重编程对EMT、肿瘤干细胞及肿瘤转移调控等方面研究取得多项开创性成果。在国际上率先发现代谢重编程在EMT诱导过程中起关键作用，并发现EMT诱导因子介导的表观遗传修饰有助于肿瘤细胞的代谢重编程和EMT发生。这些工作开创了研究EMT和肿瘤侵袭转移的新方向，研究成果通讯或第一作者发表在Cancer Cell、Journal of Experimental Medicine （2篇）、Journal of Clinical Investigation等具有国际影响力的杂志上，引起国际同行们广泛关注和认可。研究成果被Cancer Cell、Faculty of 1000等著名期刊和学术媒体重点推荐评论。迄今为至，总共发表SCI论文达30余篇，作为通讯或第一作者的SCI论文有15篇，所发表论文累计影响因子171.5，作为通讯或第一作者的论文累计影响因子达123.6，累计引用率1600余次。 学术团体和社会兼职中国生物化学与分子生物学代谢专业委员会理事、中国抗癌协会整合肿瘤学分会委员，Scientific report、Current Molecular Medicine、 Cancer、 Cancer letter、 Biochemical Journal等16个知名学术期刊特约审稿人。 学术荣誉2009：中华预防医学会科技进步奖二等奖（12）2008：中国疾病预防控制中心第四届学术学术会议科技论文二等奖2007：中国疾病预防控制中心传染病预防控制国家重点实验室第一届青年学术会议科技论文二等奖2007：中国疾病预防控制中心科技论文奖  工作研究领域主要从事肿瘤转移机制研究，包括： 1)乳腺癌代谢调控； 2)表观遗传修饰对EMT及肿瘤转移的调控； 3)乳腺癌转移功能基因和分子标记物的研究。 近期主要论文（从35篇SCI论文选取；5年平均影响因子IF，*为通讯作者）Cao Q Chen X Wu X Liao R Panpan Huang Yanjia Tan Li Wang Guoping Ren Jian Huang and Dong C*. Inhibition of UGT8 Suppresses Basal-like Breast Cancer Progression by Attenuating Sulfatide-αVβ5 Axis. J Exp Med215 (6) 1679-1692; DOI: 10.1084/JEM.20172028 2018 (IF:12.1）（通讯作者）Chen X Cao Q Wu X Liao R Xun S Huang J and Dong C*. Loss of ABAT-mediated GABAergic system promotes basal-like breast cancer progression by activating Ca2+-NFAT1 axis. Theranostics 2018 （ IF: 9.01）（通讯作者）Wu X Li X Fu Q Cao Q Chen X Wang M Yu J Long J Yao J Liu H Wang D Liao R and Dong C*. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. J Exp Med 214 (4) 1065-1079; DOI: 10.1084/jem.20160903 2017 (IF:12.1）（通讯作者）Zhu X Su D Xuan S Ma G Dai Z Liu T Tang D Mao W* and Dong C*. Gene Therapy of Gastric Cancer Using LIGHT-Secreting Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells. Gastric Cancer 16(2):155-66 2013. PMID: 22850801 (IF:5.4) （通讯作者）Dong C Yuan T Wu Y Wang Y Fan T Miriyala S Lin Y Yao J Shi J Kang T Lorkiewicz P Clair DS Hung MC Evers BM and Zhou BP. Loss of FBP1 by Snail-mediated Repression Provides Metabolic Growth Advantages in Basal-like Breast Cancer. Cancer Cell 23(3): 316-331 2013. PMID: 23453623 Commentary Coverage: Schieber MS and Chandel NS. ROS Links Glucose Metabolism to Breast Cancer Stem Cell and EMT Phenotype. Cancer Cell 23(3): 265‐267 2013. Paper was selected by Faculty 1000. (IF: 24.2)Dong C Wu Y Yao J Wang Y Yu Y Rychahou PG Evers BM and Zhou BP. G9a interacts with Snail and is critical for Snail‐mediated E‐cadherin repression in human breast cancer. J Clin Invest 122(4):1469‐86 2012. PMID: 22406531 (IF: 13.12)Dong C Wu Y Wang Y Wang C Kang TB Rychahou PG Chi Y‐I Evers BM and Zhou BP. Interaction with Suv39H1 is Critical for Snail‐mediated E‐cadherin Repression in Breast Cancer. Oncogene 14; 32(11):1351-62 2013. PMID: 22562246 (IF: 7.9) 本实验室正在招收博士硕士研究生、博士后、技术员，欢迎加盟！教学与课程:【肿瘤研究前沿】【医学基础】【现代病理学】【人体形态学实验】【临床病理学】 科研: 科研项目国家自然科学基金面上项目，2018-2022，主持国家重点研发计划慢病项目，2016-2021，课题骨干浙江省自然科学基金重点项目，2017-2020，主持国家自然科学基金面上项目2014-2018，主持中央高校基本科研业务费专项，2014-2018，主持国家“千人计划（青年千人计划项目）”，2015-2018，主持 研究与成果:目前申请发明专利 （2项） 发表论文:近年发表的主要论文（37篇SCI论文；影响因子IF，*为通讯作者）Cao Q Chen X Wu X Liao R Panpan Huang Yanjia Tan Li Wang Guoping Ren Jian Huang and Dong C*. Inhibition of UGT8 Suppresses Basal-like Breast Cancer Progression by Attenuating Sulfatide-αVβ5 Axis. J Exp Med 215 (6) 1679-1692; DOI: 10.1084/JEM.20172028 2018 (IF:12）（通讯作者）Wu X Li X Fu Q Cao Q Chen X Wang M Yu J Long J Yao J Liu H Wang D Liao R and Dong C*. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. J Exp Med 214 (4) 1065-1079; DOI: 10.1084/jem.20160903 2017 (IF:12）（通讯作者）Wang Z and Dong C*. Gluconeogenesis in Cancer: Multifaceted Functions Regulations and Targeted Therapies of Three Key Enzymes. Trends in Cancer 2017 Revised (Cell子刊) （通讯作者）Liu H Ren G Liao R Wang L Wu X Chen X Cao Q Li J and Dong C*. ME1 promotes basal-like breast cancer progression and associates with poor prognosis. Scientific reports 2018 In press (IF: 4.3）（通讯作者）Ye M Zhang Y Gao H Xu Y Jing P Wu J Zhang X Xiong J Dong C Yao L and Jian Zhang J. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small-Cell Lung Cancer by Activating Src-Mediated Bypass Signaling. Clin Cancer Res 24(5):1227-1239. doi: 10.1158/1078-0432 2018  Accepted (IF: 9.6）Wu Y Wang Y Lin Y Liu Y Wang Y Jia J Singh P Chi Y Wang C Dong C Li W Tao M Napier D Shi Q Deng J Evers M and Zhou BP. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Comun DOI: 10.1038/ncomms14228 2017 (IF: 12.1) 2010-2016论文发表情况：Zhu X Su D Xuan S Ma G Dai Z Liu T Tang D Mao W* and Dong C*. Gene Therapy of Gastric Cancer Using LIGHT-Secreting Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells. Gastric Cancer 16(2):155-66 2013. PMID: 22850801 (IF:5.4) （通讯作者）Dong C Yuan T Wu Y Wang Y Fan T Miriyala S Lin Y Yao J Shi J Kang T Lorkiewicz P Clair DS Hung MC Evers BM and Zhou BP. Loss of FBP1 by Snail-mediated Repression Provides Metabolic Growth Advantages in Basal-like Breast Cancer. Cancer Cell 23(3): 316-331 2013. PMID: 23453623 Commentary Coverage: Schieber MS and Chandel NS. ROS Links Glucose Metabolism to Breast Cancer Stem Cell and EMT Phenotype. Cancer Cell 23(3): 265‐267 2013. Paper was selected by Faculty 1000. (IF: 27.4)Dong C Wu Y Yao J Wang Y Yu Y Rychahou PG Evers BM and Zhou BP. G9a interacts with Snail and is critical for Snail‐mediated E‐cadherin repression in human breast cancer. J Clin Invest 122(4):1469‐86 2012. PMID: 22406531 (IF: 12.8)Dong C Wu Y Wang Y Wang C Kang TB Rychahou PG Chi Y‐I Evers BM and Zhou BP. Interaction with Suv39H1 is Critical for Snail‐mediated E‐cadherin Repression in Breast Cancer. Oncogene 14; 32(11):1351-62 2013. PMID: 22562246 (IF: 7.5)Liu H Li X Huixin and Dong C*. Epigenetic and metabolic regulations of breast cancer stem cells. J ZHEJIANG UNIV-SC B 16(1):10-17 2014. PMID: 25559951 (Invited review) （通讯作者）Lin Y Wu Y Li J Dong C Ye X Chi Y‐I Evers BM and Zhou BP. The SNAG Domain of Snail1 Functions as a Molecular Hook for Recruiting Lysine‐specific Demethylase 1. EMBO J 29(11):1803‐16 2010. PMID: 20389281. Commentary Coverage: Christofori G Snail1 links transcriptional control with epigenetic regulation. EMBO J 29 1787‐1789 2010. Paper was selected by Faculty 1000. (IF: 9.8)Lin Y Dong C and Zhou BP. Epigenetic Regulation of EMT: The Snail Story. Curr Pharm Des. 20(11):1698-705 2014. PMID: 23888971Dong C and Zhou BP. Snail: a target for treating basal-like breast cancer. Breast Cancer Manage 2(4) 259–262 2013Goodson William H 3rd，Lowe Leroy，Carpenter David O，Gilbertson Michael，Manaf Ali Abdul，Lopez de Cerain Salsamendi Adela，Lasfar Ahmed，Carnero Amancio，Azqueta Amaya，Amedei Amedeo，Charles Amelia K，Collins Andrew R，Ward Andrew，Salzberg Anna C，Colacci Annamaria，Olsen Ann-Karin，Berg Arthur，Barclay Barry J，Zhou Binhua P，Blanco-Aparicio Carmen，Baglole Carolyn J，Dong Chenfang，et. al. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis，2015，36 Suppl 1：S254-S296. PMID: 26106142 (Invited review for one chapter)Ochieng Josiah ，Nangami Gladys N，Ogunkua Olugbemiga，MiousseIsabelle R，Koturbash Igor，Odero-Marah Valerie，McCawley Lisa J，Nangia-Makker Pratima，Ahmed Nuzhat，Luqmani Yunus，Chen Zhenbang，Papagerakis Silvana，Wolf Gregory T，Dong Chenfang，et. al. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis，2015，36 Suppl 1：S128-S159. PMID: 26106135 (Invited review for one chapter) 2010年以前主要论文发表情况：Dong C Shi S Wang XF An R Li P Chen JM Wang X Wang GR. Shan B Zhang BY Han J and Dong XP. The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 470:83-92 2007. PMID: 18037369Dong C Huang YX An R Chen JM Wang XF Shan B Lei YJ Han L Zhang B Han J and Dong XP. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation. Zoonoses Public Health 54:328‐336 2007. PMID: 17894644Dong C Wang XF Wang X Shi S Wang GR Shan B An R Li XL Zhang BY Han J and Dong XP. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Med Microbiol Immunol 197:361‐368 2008. PMID: 17894644Li XL* Dong C* Wang GR Zhou RM Shi Q Tian C Gao C Mei GY Chen C Xu K Han J and Dong XP. Manganese‐induced changes of the biochemical characteristics of the recombinant wild‐type and mutant PrPs. Med Microbiol Immunol 198:239‐245 2009. PMID: 19633867 (* Equal contribution)Li X* Dong C* Shi S Wang G Li Y Wang X Shi Q Tian C Zhou R Gao C and Dong XP. The octarepeat region of hamster PrP (PrP51‐91) enhances the formation of microtubule and antagonize Cu (2+)‐induced microtubule‐disrupting activity. Acta Biochim Biophys Sin (Shanghai) 41:929‐937 2009. PMID: 19902127 (* Equal contribution)Wang XF Dong C Zhang J Wan YZ Li F Huang YX Han L Shan B Gao C Han J and Dong XP. Human tau protein forms complex with PrP and some GSS‐ and fCJD‐related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem 310:49‐55 2008. PMID: 18038270An R Dong C Lei Y Han L Li P Chen J Wang G Shi Q Gao C Jiang H Zhou W Han J Chu Y and Dong X. PrP mutants with different numbers of octarepeat sequences are more susceptible to the oxidative stress. Sci China C Life Sci 51:630‐639 2008. PMID: 18622746Li P Dong C Lei Y Shan B Xiao X Jiang H Wang X Gao C Shi Q Xu K Tian C Han J and Dong X. Doppel‐induced cytotoxicity in human neuronal SH‐SY5Y cells is antagonized by the prion protein. Acta Biochim Biophys Sin (Shanghai) 41:42‐53 2009. PMID: 19129949Shi S Dong C Wang GR Wang X An R Chen JM Shan B Zhang BY Xu K Shi Q Tian C Gao C Han J and Dong XP. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification. Virus Res 141:26‐33 2009. PMID: 19162101Shi S Dong C Tian C Zhou RM Xu K Zhang BY Gao C Han J and Dong XP The propagation of hamsteradapted scrapie PrPSc can be enhanced by reduced pyridine nucleotide in vitro. FEBS J 276:1536‐1545 2009. PMID: 19220459Wang X Dong C Shi Q Shi S Wang GR Lei YJ Xu K An R Chen JM Jiang HY Tian C Gao C Zhao YJ Han J and Dong XP. Cytosolic prion protein induces apoptosis in human neuronal cell SH‐SY5Y via mitochondrial disruption pathway. BMB Rep 42:444‐449 2009. PMID: 19643043Huang YX Han J Dong C Sun L Gao C Wang XF Han L Zhou W Zhang BY Jiang HY Liang MF and Dong XP. Generation of genetic engineering monoclonal antibodies against prion protein. Med Microbiol Immunol 196:241‐246 2007. PMID: 17486363Li X Wang J Wang Z Dong C Dong X Jing Y Yuan Y and Fan G. Tumor necrosis factor-alpha of Red nucleus involved in the development of neuropathic allodynia. Brain Res Bull 77:233-236 2008. PMID: 18824078Chen JM Gao C Shi Q Shan B Lei YJ Dong C An R Wang GR Zhang BY Han J and Dong XP. Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Arch Virol 153:1013-1020 2008. PMID: 18037369Chen J Gao C Shi Q Wang G Lei Y Shan B Zhang B Dong C Shi S Wang X Tian C Han J and Dong X. Casein kinase II interacts with prion protein in vitro and forms complex with native prion protein in vivo. Acta Biochim Biophys Sin (Shanghai) 40:1039-1047 2008. PMID: 19089302Li XL Wang GR Jing YY Pan MM Dong C Zhou RM Wang ZY Shi Q Gao C and Dong XP. Cytosolic PrP induces apoptosis of cell by disrupting microtubule assembly. J Mol Neurosci 43:316-325 2011. PMID: 20838930Shan B Gao C Chen JM Bi XY Zhang BY Guo Y Dong C An R Shi Q Hu JQ Zhao P Han J and Dong XP. Establishment of a sandwich ELISA method for detection of vascular endothelial growth factor in serum samples of hepatocellular carcinoma patients. Biomed Environ Sci 21:69-74 2008. PMID: 18478981Wang GR Gao C Shi Q Zhou W Chen JM Dong C Shi S Wang X Wei Y Jiang HY Han J and Dong XP. Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease. Am J Med Sci 340:291-295 2010. PMID: 20881758Wang GR Shi S Gao C Zhang BY Tian C Dong C Zhou RM Li X.L Chen C Han J and Dong XP. Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases. BMC Infect Dis 10:86 2010. PMID: 20356412Lei YJ Gao C Wang C Han J Chen JM Xiang GC Shi Q Jiang HY Zhou W An R Dong C Yuan YK and Dong XP. Molecular epidemiological study on prevalence of human papillomaviruses in patients with common warts in Beijing area. Biomed Environ Sci 22:55-61 2009. PMID: 19462689Chen SL Zhang YX Xu MY Ji XS Yu GC and Dong C. Molecular polymorphism and expression analysis of MHC class II B gene from red sea bream (Chrysophrys major). Dev Comp Immunol 30:407-418 2006. PMID: 16045985新闻报道:文章1：Cao Q Chen X Wu X Liao R Panpan Huang Yanjia Tan Li Wang Guoping Ren Jian Huang and Dong C*. Inhibition of UGT8 Suppresses Basal-like Breast Cancer Progression by Attenuating Sulfatide-αVβ5 Axis. J Exp Med 215 (6) 1679-1692; DOI: 10.1084/JEM.20172028 2018 (IF:12）中文媒体报道：被上百家媒体（包括： 新华社、凤凰网、新浪、搜狐、网易等）广泛报道或转载。浙江日报董辰方介绍UGT8酶在三阴性乳腺癌中的表达程度非常高是其在正常细胞或乳腺癌的其他亚型中的4到8倍有利于作为靶向分子。研究实验表明唑来膦酸在...zjrb.zjol.com.cn/html/...  - 百度快照...的药物或可治乳腺癌|乳腺癌|骨质疏松|唑来膦酸_新浪新闻...2018年5月6日 - 新华社华盛顿5月5日电(记者周舟)中国浙江大学医学院董辰方教授课题组最新发现用于治疗骨质疏松症的“唑来膦酸”能有效抑制基底细胞样乳腺癌的扩散和...news.sina.com.cn/w/201...  - 百度快照一骨质疏松药或可治乳腺癌_搜狐科技_搜狐网2018年5月14日 - 董辰方介绍UGT8酶在三阴性乳腺癌中的表达程度非常高是其在正常细胞或乳腺癌的其他亚型中的4倍～8倍有利于作为靶向分子。研究表明唑来膦酸在体外...www.sohu.com/a/2315192...  - 百度快照治疗骨质疏松的药物或可治乳腺癌 - 现代金报数字报刊平台2018年5月7日 - 中国浙江大学医学院董辰方教授课题组最新发现用于治疗骨质疏松症的“唑来膦酸”能有效抑制基底细胞样乳腺癌的扩散和转移有望成为治疗这种恶性肿瘤...dzb.jinbaonet.com/html...  - 百度快照董辰方教授课题组再次揭示骨质疏松药物或可靶向治疗致...-浙江大学2018年5月8日 - 5月4日国际顶级学术期刊JEM在线发表了浙江大学基础医学院肿瘤中心董辰方教授(...更为重要的是该研究证实一种治疗骨质疏松的上市药物-唑来膦酸是UGT8...www.zju.edu.cn/2018/05...  - 百度快照JEM:浙江大学董辰方教授课题组揭示骨质疏松药物或可靶向..._生物帮2018年5月10日 - 《Journal of Experimental Medicine》在线发表了浙江大学基础医学院肿瘤中心董辰方...本研究证实了唑来膦酸是UGT8直接的抑制剂有潜力成为治疗基底样...www.bio1000.com/gnjz/i...  - 百度快照一骨质疏松药或可治乳腺癌- 苏州大学附属第一医院药学部 -2018年5月22日 - 人体内一种名为尿苷二磷酸糖基转移酶8(UGT8)的酶在三阴性乳腺癌中的表达程度非常高而骨质疏松药物唑来膦酸是UGT8的直接抑制剂。浙江大学医学院董辰方...www1.sdfyy.cn/yjkweb/w...  - 百度快照浙大医学院最新发现:治疗骨质疏松的药物或可治乳腺癌2018年5月6日 - 中国浙江大学医学院董辰方教授课题组最新发现用于治疗骨质疏松症的“唑来膦酸”能有效抑制基底细胞样乳腺癌的扩散和转移有望成为治疗这种恶性肿瘤的靶向药物。相关...baijiahao.baidu.com/s?...  - 百度快照浙大专家发现:骨质疏松药物或可治疗致命性乳腺癌_浙江频道_凤凰网2018年5月6日 - 董辰方介绍UGT8酶在三阴性乳腺癌中的表达程度非常高是其在正常细胞或乳腺癌的其他亚型中的4到8倍有利于作为靶向分子。研究实验表明唑来膦酸在体...zj.ifeng.com/a/2018050...  - 百度快照一骨质疏松药或可治乳腺癌2018年5月14日 - 董辰方介绍UGT8酶在三阴性乳腺癌中的表达程度非常高是其在正常细胞或乳腺癌的其他亚型中的4倍～8倍有利于作为靶向分子。研究表明唑来膦酸在...www.huaxia.com/hxjk/jk...  - 百度快照治疗骨质疏松的药物或可治乳腺癌-新华网治疗骨质疏松的药物或可治乳腺癌 ---中国浙江大学医学院董辰方教授课题组最新发现用于治疗骨质疏松症的“唑来膦酸”能有效抑制基底细胞样乳腺癌的扩散...www.xinhuanet.com/tech...  - 百度快照最新发现!治疗骨质疏松的药物或可治乳腺癌_畅说本地_本地108生活...中国浙江大学医学院董辰方教授课题组最新发现用于治疗骨质疏松症的“唑来膦酸”能有效抑制基底细胞样乳腺癌的扩散和转移有望成为治疗这种恶性肿瘤的靶向药物。相关...外文媒体报道：https://jemrupress.altmetric.com/details/40719806/newsOsteoporosis Drug Could Be Used to Treat Aggressive Form of Breast CancerALN 08 May 2018Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer an…Osteoporosis drug could be used to treat aggressive form of breast cancer. ecancerecancer 08 May 2018Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer an…Descubren un fármaco contra la osteoporosis que ayudar a combatir el cáncer de mama más agresivoJano 08 May 2018PUBLICADO EN JOURNAL OF EXPERIMENTAL MEDICINE JEM · 08 mayo 2018 00:58 Un equipo de investigadores de la Universidad Zhejiang…Un medicamento para la osteoporosis podría usarse para tratar formas agresivas de cáncer de mamaEl Economista 07 May 2018Investigadores en China han descubierto que una enzima llamada UGT8 impulsa la progresión del cáncer de mama de tipo basal una…Researchers find another use for osteoporosis drugShanghai Daily 06 May 2018CHINESE researchers discovered that a widely used osteoporosis drug might prevent the spread of a particular aggressive form of…Un fármaco contra la osteoporosis podría ayudar a combatir el cáncer de mama basalLa Vanguardia 05 May 2018Un equipo de investigadores de la Facultad de Medicina de la Universidad Zhejiang en Hangzhou (China) acaba de hacer un…Chinese scientists find therapy in osteoporosis drug for breast cancerKazinform 05 May 2018WASHINGTON. KAZINFORM Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a…Common drug may help battle aggressive breast cancerMedical News Today 05 May 2018Basal-like breast cancer affects women at a relatively young age and is challenging to treat.Chinese scientists find therapy in osteoporosis drug for breast cancer - XinhuaXinhua 05 May 2018WASHINGTON May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a…Osteoporosis drug prevents spread of basal-like breast cancer in miceThe Medical News 04 May 2018Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer an…Chinese scientists find therapy in osteoporosis drug for breast cancerChina.org 04 May 2018WASHINGTON May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a…Hallado un fármaco capaz de prevenir las metástasis del cáncer de mama más letalLa Voz Digital 04 May 2018Ya aprobado para el tratamiento de la osteoporosis el ácido zoledrónico inhibe una enzima necesaria para la supervivencia y…Hallado un fármaco capaz de prevenir las metástasis del cáncer de mama más letalABC desevilla 04 May 2018ABC ES NOTICIA Salud Supresión de tumores metastásico en el pulmón de ratones tratados con ácido zoledrónico (derecha) …Osteoporosis Drug Could Be Used to Treat Aggressive Form of Breast Cancer Researchers SayNewswise 04 May 2018Return to Article List Article ID: 693698 Released: 30-Apr-2018 9:40 AM EDT Source Newsroom: The Rockefeller University Press…Osteoporosis drug could be used to treat aggressive form of breast cancer researchers sayScience Daily 04 May 2018Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer an…Osteoporosis drug could be used to treat aggressive form of breast cancer researchers sayEurekAlert! 04 May 2018Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer an…Osteoporosis drug could be used to treat aggressive form of breast cancer researchers sayMedicalXpress 04 May 2018Home Cancer May 4 2018 May 4 2018 Rockefeller University Press Researchers in China have discovered that an enzyme called文章2：Wu X Li X Fu Q Cao Q Chen X Wang M Yu J Long J Yao J Liu H Wang D Liao R and Dong C*. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. J Exp Med 214 (4) 1065-1079; DOI: 10.1084/jem.20160903 2017 (IF:12）中文媒体报道：被上百家媒体（包括： 新华社、央视网、浙江卫视、凤凰网、新浪、搜狐、网易等）广泛报道或转载。董辰方团队揭示致命性乳腺癌转移扩散分子机制中国教育  2017年03月20日 09:59全球每年新增120万例的左右乳腺癌患者基底样型乳腺癌是其中最为凶险的一个亚型。浙江大学医学院肿瘤研究中心董辰方教授团队揭示:一种名为AKR1B1的酶能为癌细胞‘...查看更多相关新闻>>  -  百度快照JEM:浙江大学董辰方团队证实糖尿病药物依帕司他或可治疗基底样...生物谷  2017年03月09日 14:002017年3月9日/生物谷BIOON/---在一项新的研究中来自中国浙江大学医学院的研究人员发现一种被称作AKR1B1的代谢酶促进一种侵袭性的乳腺癌产生。这一发现提示着当... 百度快照...浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物...每日经济新闻  2017年03月18日 15:46【我国学者发现一糖尿病治疗药物或可治疗三阴性乳腺癌】浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能有效抑制乳腺癌细胞该药物有...查看更多相关新闻>>  -  百度快照三阴乳腺癌有了新靶向药?网易  2017年03月19日 04:04据新华社报道浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能有效抑制乳腺癌细胞该药物有望成为治疗致命性乳腺癌的有效靶向药物。 这...查看更多相关新闻>>  -  百度快照浙大科学家团队取得关键发现糖尿病药物或“跨界”治疗乳腺癌网易  2017年03月19日 01:59董辰方表示。 新发现可喜动物实验已经取得一定成果 这一发现意味着AKR1B1抑制剂不光能治糖尿病还可以作为治疗三阴性乳腺癌的有效靶向药物。为了验证这一大胆猜想... 百度快照浙大科学家发现已获批糖尿病药物或可治致命性乳腺癌网易  2017年03月16日 09:51来自中国浙江大学的董辰方教授研究团队终于找到了答案。他们发现在基底样乳腺癌细胞里有一种叫做AKR1B1的酶异常活跃这个酶竟然可以间接「解放」癌细胞让原本被... 查看更多相关新闻>>  -  百度快照浙大医学院新发现!糖尿病药物或可治疗乳腺癌?!新蓝网  2017年04月01日 19:00近日浙大医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能够有效抑制三阴性乳腺癌细胞扩散。该药物有希望成为治疗该致命性乳腺癌的有效靶向药物。 百度快照我国学者发现一糖尿病治疗药物或可治疗三阴性乳腺癌新华网  2017年03月18日 15:16我国学者发现一糖尿病治疗药物或可治疗三阴性乳腺癌---浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能有效抑制乳腺癌细胞该药物有...查看更多相关新闻>>  -  百度快照浙大科学家发现糖尿病药物 或可治疗致命性乳腺癌浙江在线  2017年03月18日 11:55董辰方教授(左一) 浙江在线3月18日讯(浙江在线记者 曾福泉 通讯员 周炜)浙江大学科学家首次发现人体内一种酶对三阴性乳腺癌的转移扩散产生重要作用并指出当前一... 查看更多相关新闻>>  -  百度快照我国发现一糖尿病治疗药物 或可治疗三阴性乳腺癌网易  2017年03月19日 00:02据新华社电浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能有效抑制乳腺癌细胞该药物有望成为治疗致命性乳腺癌的有效靶向药物。... 百度快照一种糖尿病药物有望治疗致命性乳腺癌凤凰网  2017年03月22日 13:56“很巧的是一种已知的药物能抑制AKR1B1的活性——依帕司他(Epalrestat)目前已在临床上用于治疗糖尿病外周神经病变。”董辰方课题组通过细胞和小鼠验证了这一药物... 查看更多相关新闻>>  -  百度快照中国学者发现糖尿病药治乳腺癌新浪  2017年04月06日 09:43来自浙江大学医学院的董辰方研究团队发现作为治疗糖尿病神经病变的药物依帕司他(epalrestat)在小鼠的乳腺癌模型中有很好的疗效其抑 百度快照糖尿病治疗药物或可治疗乳腺癌深圳商报  2017年03月19日 02:07【新华社杭州3月18日电】浙江大学医学院董辰方教授课题组发现治疗糖尿病并发症的药物“依帕司他”能有效抑制乳腺癌细胞该药物有望成为治疗致命性乳腺癌的有效... 百度快照浙大科学家团队取得关键发现_搜狐新闻_搜狐网2017年3月19日 - 就在近日浙大医学院董辰方教授团队发表在国际著名期刊《实验医学杂志》(Journal of Experimental Medicine)上的论文揭示一种名为AKR1B1的醛酮还原酶可...www.sohu.com/a/1293132...  - 百度快照J Exp Med:浙大董辰方教授发现糖尿病药物对乳腺癌有积极作用-Med...2017年3月13日 - 自中国浙江大学董辰方教授团队风险一种名为 AKR1B1 的代谢酶对乳腺癌的作用。研究表示AKR1B1 可以通过积极的反馈回路促进基底细胞型乳腺癌的发展。...www.medsci.cn/article/...  - 百度快照 我国学者在基底样型乳腺癌转移机制方面取得重要进展2017年3月24日 - 董辰方研究团队发现代谢酶AKR1B1在基底样型乳腺癌和三阴性乳腺癌中表达显著升高其高表达与肿瘤转移及患者低生存率正相关。EMT诱导因子Twist2能促进...health.nsfc.gov.cn/htm...  - 百度快照一种糖尿病药物有望治疗致命性乳腺癌-光明日报-光明网2017年3月22日 - 本报杭州3月21日电 记者严红枫 日前从浙江大学医学院了解到该校肿瘤研究中心董辰方教授团队揭示:一种名为AKR1B1的酶让乳腺癌细胞“肆虐”而能“捆...epaper.gmw.cn/gmrb/htm...  - 百度快照董辰方团队揭示致命性乳腺癌转移扩散分子机制2017年3月20日 - 全球每年新增120万例的左右乳腺癌患者基底样型乳腺癌是其中最为凶险的一个亚型。浙江大学医学院肿瘤研究中心董辰方教授团队揭示:一种名为AKR1B1的酶...  - 百度快照  英文媒体报道：https://jemrupress.altmetric.com/details/17083024 So far Altmetric has seen 35 news stories from 33 outlets.Diabetes drug may help treat breast cancerDaijiworld.com 21 Mar 2017Sun Mar 19 2017 01:13:00 PM Beijing March 19 (IANS): Chinese researchers have found that a drug used to treat diabetes could…Diabetes drug may help treat breast cancerMid-Day.com 20 Mar 2017Prev Representational image Beijing: Chinese researchers have found that a drug used to treat diabetes could be effective…Diabetes Drug Could Prevent Spread Of Aggressive Breast CancerAsian Scientist 20 Mar 2017A drug that has already been approved for treating diabetes has been shown to inhibit an enzyme that drives an aggressive type…Diabetes drug could halt breast cancerShanghai Daily 19 Mar 2017RESEARCHERS in China have discovered that a drug used to treat diabetes could be effective against a form of deadly breast…Researchers: Diabetes drug may help treat breast cancerThe Star Online 19 Mar 2017HANGZHOU: Researchers in China have discovered that a drug used to treat diabetes could be effective against a form of deadly…Drug used for diabetes could be effective against breast cancerTimes of India 19 Mar 2017BEIJING: Chinese researchers have found that a drug used to treat diabetes could be effective against a form of breast cancer.Some hope for breast cancer patients with this diabetes drugZee News (India) 19 Mar 2017New Delhi: Researchers from China have found that a drug used to treat diabetes could be effective against a form of breast…Diabetes drug may help treat breast cancerThe Siasat Daily 19 Mar 2017Beijing: Chinese researchers have found that a drug used to treat diabetes could be effective against a form of breast cancer.Diabetes drug may help treat breast cancerYahoo! News 19 Mar 2017Beijing March 19 (IANS) Chinese researchers have found that a drug used to treat diabetes could be effective against a form of…Diabetes drug may help treat breast cancerCanIndia 19 Mar 2017March 19th 2017 0 comments 0 Beijing March 19 (IANS) Chinese researchers have found that a drug used to treat diabetes could…Diabetes drug may help treat breast cancer: Chinese researchersPeoples Daily (China - English) 19 Mar 2017Researchers in China have discovered that a drug used to treat diabetes could be effective against a form of deadly breast…Diabetes drug may help treat breast cancer- China.org.cnChina.org 19 Mar 2017Researchers in China have discovered that a drug used to treat diabetes could be effective against a form of deadly breast…Diabetes drug may help treat breast cancerForeign Affairs New Zealand 19 Mar 2017MIL OSI China – Source: China State Council Information Office Headline: Researchers in China have discovered that a drug used…Obat Diabetes Bisa Bantu Atasi Kanker PayudaraBerita Satu 19 Mar 2017Hangzhou - Para peneliti di Tiongkok mendapati obat untuk diabetes bisa efektif untuk melawan kanker payudara yang mematikan.Diabetes drug may help treat breast cancer: Chinese researchers - XinhuaXinhua 19 Mar 2017HANGZHOU March 18 (Xinhua) -- Researchers in China have discovered that a drug used to treat diabetes could be effective…董辰方团队揭示致命性乳腺癌转移扩散分子机制—新闻—科学网Sciencenet (CHN) 19 Mar 2017董辰方团队揭示致命性乳腺癌转移扩散分子机制 一种糖尿病药物有望“老药新用” 全球每年新增120万例的左右乳腺癌患者，基底样型乳腺癌是其中最为凶险的一个亚型。浙江大学医学院肿瘤研究中心董辰方教授团队揭示：一种名为AKR1B1的酶能为癌细胞‘松绑’，为其扩散转移…Diabetes drug may help treat breast cancer: Chinese researchersChina Daily 18 Mar 2017HANGZHOU - Researchers in China have discovered that a drug used to treat diabetes could be effective against a form of deadly…Diabetes drug may help treat deadly breast cancer says Chinese researchersZee News (India) 18 Mar 2017Beijing: Chinese researchers have discovered that diabetes drug may help in treating the deadly disease breast cancer a state…Diabetes drug may help treat breast cancer:Chinese researchersBusiness Standard 18 Mar 2017Chinese researchers have discovered that a drug used to treat diabetes could be effective against a form of deadly breast cancer…Diabetes drug may help treat breast cancer:Chinese researchersDaily News & Analysis (dna) 18 Mar 2017Chinese researchers have discovered that a drug used to treat diabetes could be effective against a form of deadly breast cancer…15:11 Diabetes drug may help treat breast cancer: Chinese researchersAsia Pacific Daily 18 Mar 2017Diabetes drug may help treat breast cancer: Chinese researchers Xinhua News Agency | Sat2017-03-18 HANGZHOU March 18 (Xinhua) …Diabetes Drug May Be Effective Against Cancer Deadly Form of Breast CancerDrug Discovery and Development  15 Mar 2017Compared to a control (left) epalrestat treatment (right) reduces the number of metastatic tumors (arrowheads) in the lungs of…Diabetes drug may be effective against deadly form of breast cancer study suggestsMedical News Today 09 Mar 2017Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer.Un fármaco para la diabetes resulta eficaz contra una forma agresiva del cáncer de mamaLainformacion.com  08 Mar 2017Investigadores de la Universidad de Zhejiang en Hangzhou (China) han descubierto una enzima metabólica llamada AKR1B1 que…Un fármaco para la diabetes resulta eficaz contra una forma agresiva del cáncer de mamaEl Economista 08 Mar 2017Investigadores de la Universidad de Zhejiang en Hangzhou (China) han descubierto una enzima metabólica llamada AKR1B1 que…Diabetes drug epalrestat may be effective against deadly form of breast cancer. ecancerecancer 08 Mar 2017Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer.Study Suggests Diabetes Drug May Be Effective Against Deadly Form of Breast CancerScicasts 07 Mar 2017Compared to a control (left) epalrestat treatment (right) reduces the number of metastatic tumors (arrowheads) in the lungs of…Diabetes drug may be effective against deadly form of breast cancer study suggestsHealth Medicinet 07 Mar 2017Researchers in China have detected that a metabolic enzyme called AKR1B1 drives an assertive form of breast cancer.Diabetes drug may be effective against deadly form of breast cancer study suggestsHealth Medicinet 07 Mar 2017Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer.Diabetes drug may protect against deadly form of breast cancerBreitbart News Network 07 Mar 2017SIGN UP FOR OUR NEWSLETTER March 7 (UPI) — Researchers in China have discovered a metabolic enzyme inhibitor called epalrestat…Diabetes drug may protect against deadly form of breast cancerUPI.com 07 Mar 2017March 7 (UPI) -- Researchers in China have discovered a metabolic enzyme inhibitor called epalrestat used to treat…Diabetes drug may be effective against deadly form of breast cancer study suggestsMedicalXpress 07 Mar 2017Compared to a control (left) epalrestat treatment (right) reduces the number of metastatic tumors (arrowheads) in the lungs of…Diabetes medication could be effective therapy for aggressive type of breast cancerThe Medical News 07 Mar 2017at 11:43 AM Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast…Diabetes Drug May Be Effective Against Deadly Form of Breast Cancer Study SuggestsNewswise 07 Mar 2017Return to Article List Next Article > Article ID: 670709 Released: 7-Mar-2017 9:05 AM EST Source Newsroom: The Rockefeller…Epalrestat抑制肿瘤转移EurekAlert! 07 Mar 2017Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer. 